Install
PR Newswire’s news distribution, targeting, monitoring and marketing solutions help you connect and engage with target audiences across the globe.
- 5,336articles · 30d
- 6+ hour agolatest article
- Aug 15, 2026earliest in window
- 92%with images
- 272avg words
- Economy, Business & Finance 2,509
- Finance & Business 1,999
- News 1,336
- Business & Industrial 700
- Science & Technology 593
- Health & Wellness 556
- Medical 514
- Arts, Culture, Entertainment & Media 460
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - CAPR
3+ day, 21+ hour ago (147+ words) Sep 10, 2026, 10:00 ET The class action concerns whether Capricor and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. You have until September 28, 2026, to ask the Court to appoint you as Lead Plaintiff…...
CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before September 28 Deadline
4+ day, 14+ hour ago (330+ words) Sep 09, 2026, 17:02 ET Hagens Berman encourages investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) who suffered substantial losses to submit your losses now. FDA Extends BLA Review Following Post-AdCom Submissions On Aug. 24, Capricor announced that the FDA has extended the Prescription Drug…...
CAPR Lawsuit Alert: Capricor Therapeutics Investors Face September 28 Deadline After 64% Stock Drop Tied to Clinical Data Disclosure
6+ day, 1+ hour ago (279+ words) Sep 08, 2026, 06:06 ET Capricor Therapeutics, Inc. has been sued for securities fraud over alleged misstatements about Deramiocel and the integrity of the clinical data supporting its Biologics License Application leading to a 64% stock drop. NEW YORK, Sept. 8, 2026 /PRNewswire/ -- Leading securities law…...
Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR
3+ week, 2+ day ago (290+ words) PR Newswire NEW ORLEANS, Aug. 21, 2026 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 28, 2026 to file lead plaintiff applications in a securities class action lawsuit against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NasdaqGS: CAPR),…...